3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Cancer, Papillary
1
Polycystic Ovary Syndrome
1
Infertility
1
Head and Neck Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Iodine-131
5
dabrafenib
4
Vemurafenib
4
Magnetic Resonance Spectroscopy
4
trametinib
3
lenvatinib
3
Transurethral Resection of Prostate
3
Thyrotropin Alfa
3
Thyroidectomy
3
selpercatinib
2
cobimetinib
2
X-Rays
2
Thyroid (USP)
2
Surgical Procedures, Operative
2
Sunitinib
2
Specimen Handling
2
Radiofrequency Ablation
2
Interviews as Topic
2
vandetanib
1
tremelimumab
1
spartalizumab
1
pembrolizumab
1
pazopanib
1
durvalumab
1
delta 24-sterol reductase
1
copanlisib
1
cabozantinib
1
Whole Body Imaging
1
Thyrotropin
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Cancer, Papillary
×
Thyrotropin
×
Clear all
NCT00415233
2023-12-19
HiLo
University College, London
Phase 3
Unknown
438 enrolled